Press release
Global Oncolytic Virus Therapy Market size, share, market intelligence, company profiles, market trends, growth, strategy, research report, analysis, overview, forecast 2018-2023
According to OMR analysis, the Global Oncolytic Virus Therapy Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumor cells by stimulating the host anti-tumor immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma. Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialized, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer.A full report of Global Oncolytic Virus Therapy Market is available at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market/
Furthermore, the Global Oncolytic Virus Therapy Market is segmented into by type, by use, by product and by end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Market, By Product
• HSV-Based Oncolytic Viruses
• Adenoviruses-Based Oncolytic Viruses
• Vaccinia Virus-Based Oncolytic Viruses
• Vesicular Stomatitis Virus-Based Oncolytic Viruses
• Newcastle Disease Virus-Based Oncolytic Viruses
2. Global Market, By Application
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others
Region Covered
• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, Italy, and ROE)
• Asia-Pacific (China, India, Japan, and ROAP)
• Rest of the World
Company Profile
• Amgen
• BioVex Inc.,
• Cold Genesys, Inc.
• Crusade Laboratories
• Cynvec LLC
• Genelux Corp.
• JennerRex Co. Ltd
• Lokon Pharma AB
• MediGene AG
• Merck
• Neotropix, Inc.
• Oncolys BioPharma
• Oncolytics Biotech, Inc.
• Onyx
• Otsuka Pharmaceuticals Co. Ltd
• PsiOxus Therapeutics Ltd
• Roche
• Shanghai Sunway Biotech Co. Ltd
• Silajen Biotherapeutics, Inc.
• Sorrento Therapeutics
• SunWay Biotech Co. Ltd
• Takara Bio, Inc.
• Targovax
• Theravir
• TILT Biotherapeutics
• Transgene SA
• VCN Biosciences SL
• Viralytics Ltd
• Vyriad
For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Oncolytic Virus Therapy Market size, share, market intelligence, company profiles, market trends, growth, strategy, research report, analysis, overview, forecast 2018-2023 here
News-ID: 1663574 • Views: …
More Releases from Orion Market Research

Biocatalysis and Biocatalysts Market Overview: Growth, Share, Value, Size, and S …
In 2023, the Biocatalysis and Biocatalysts Market was estimated at approximately USD 3.5 billion, and by 2033, it is expected to reach around USD 7.2 billion, implying a CAGR of about 7.5% from 2024 to 2033.
Biocatalysis and Biocatalysts Market Overview
The Biocatalysis and Biocatalysts Market is experiencing strong growth as industries increasingly adopt enzyme-driven and whole-cell catalysis for sustainable and efficient chemical processes. This market spans applications in pharmaceuticals, food and…

Automotive Coolant Market: Emerging Trends and Growth Forecast to 2033
In 2023, the Automotive Coolant Market was valued at approximately USD 7.59 billion, and by 2033, it is projected to reach approximately USD 8.31 billion, reflecting a CAGR of about 4.9% from 2024 to 2033.
Automotive Coolant Market Overview
The Automotive Coolant Market is expanding steadily, driven by increasing global vehicle production, rising demand for high-performance engines, and growing emphasis on efficient thermal management systems. Automotive coolants are essential for regulating engine…

Anti Osteoporosis Therapy and Fracture Healing Market - Industry Trends and Fore …
In 2023, the Anti-Osteoporosis Therapy and Fracture Healing Market was valued at about USD 14.05 billion, and by 2033, it is anticipated to grow to approximately USD 22.43 billion, with a CAGR of around 4.8% from 2024 to 2033.
Anti Osteoporosis Therapy and Fracture Healing Market Overview
The Anti-Osteoporosis Therapy and Fracture Healing Market is experiencing steady expansion, driven by a rising prevalence of osteoporosis and age-related fractures globally. This market encompasses…

Photographic Service Market Size Analysis, Competitive Insights, Leading Players …
In 2023, the global Photographic Service Market was approximately USD 43.1 billion, and by 2033, it is projected to reach approximately USD 82-85 billion, reflecting a compound annual growth rate of around 4.4% from 2024 to 2033.
Photographic Service Market Overview
The Photographic Services Market continues to expand steadily, anchored by robust demand for visual storytelling across social media, e-commerce, personal milestones, and branding efforts. The industry spans a broad service spectrum-from…
More Releases for Oncolytic
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth?
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering…
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer.
Download Report:
https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas
The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take…
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy.
New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate…
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Oncolytic Virus Competitive Landscape Report
• DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…